Tumour agnostic targeted agents and ‘smarter’ dynamic designs are two major areas of interest leading to more patient-centric approaches in cancer care
However, there are still many obstacles faced by investigators in achieving effective patient involvement in research
The 2023 ESMO TAT Honorary Awardee Prof. Susan E. Bates gives an overview of the lasting challenges and unfulfilled potential of these therapies
Integrated, comprehensive databases may help to close the gap in cancer care between high- and low-/lower-middle-income countries
While some challenges associated with rare cancers are similar in Europe and Asia, resources and differing epidemiology need to be considered when coming up with solutions
Results from a pilot study show that work–family balance is the biggest challenge to career progression for young women
Despite the promises shown by some innovative technologies in the studies presented, they will not replace existing diagnostic modalities soon
AI technology is being tested across tumour types and with different purposes, with an emerging trend for adding value to whole slide image analyses for HER2 status
A study presented at ESMO Congress 2022 highlights the need to identify predictors of anticancer drug toxicity as more complex treatments become available
While local and regional initiatives address some major barriers, global efforts are needed to make molecularly guided options accessible to all patients.
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.